BLACK WEEKSVialer −15% · kit −10% · övrigt −5%med kodFri frakt inom Tyskland från €200

Den här sidan har översatts automatiskt och kan innehålla fel. Har du svenska som modersmål? Vi tar gärna emot din feedback och dina förbättringar.Skicka feedback

The Peptide Desk The Peptide Desk
Cabergoline, produktfoto
PCT & AI

Cabergoline

PCT & AI

  • Skickas från Tyskland

Beställning

Styckpris - Fri frakt inom Tyskland från 200 € under Black Weeks
  • DHL med spårning
  • Diskret förpackning

4.6 av 5 på Trustpilot73 omdömen

Söks även som: Cabergolin

I korthet

Cabergoline i siffror

Nyckeltalen från vårt lexikon. Dra punkten längs kurvan för att se hur mycket som finns kvar efter en dos, beräknat.

Hela lexikonartikeln

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~2.9 days

Half-life ~2.9 days
After 5.8 days: 25 %
Day 2.950 %Day 5.825 %Day 8.812.4 %Day 14.63.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about70hours

Class
Dopamine D2 receptor agonist
Use
Oral1-2x per week
Sizes
0.25 to 0.5 mg2 sizes in the shop

Det finns ännu ingen labbanalys för Cabergoline. Rösta på denLåt testa själv, vi betalar halvaAlla labbanalyser

Kunskap

Allt om Cabergoline

FAQ

Vanliga frågor

Källor till varje svar: lexikonartikel

Har du fortfarande en fråga?

Skriv till oss, vårt team hjälper dig.

How does cabergoline lower prolactin?

Cabergoline binds as an agonist to the dopamine D2 receptor. Dopamine is the natural brake on the prolactin cells in the pituitary. According to the label it has only low affinity for other receptors such as D1, alpha adrenoceptors and serotonin receptors.

Is cabergoline approved?

Yes. ChEMBL lists cabergoline as an approved compound with first approval in 1996. On ClinicalTrials.gov 83 trials list cabergoline (as of 26 October 2026). Everything here is the state of research, not a recommendation.

Is it better than bromocriptine?

In the large comparison trial with 459 women yes: prolactin was stably normal in 83 instead of 59 percent, 72 instead of 52 percent ovulated or became pregnant. Side effects occurred in 68 instead of 78 percent, 3 instead of 12 percent stopped. A French trial with 120 women came to the same result.

What about the heart valves?

The label requires a heart ultrasound before starting and checks every 6 to 12 months. Valve changes occurred mostly at high doses in Parkinson's treatment, but there are also cases at lower doses. In a cohort study in Parkinson's the rate was 68 per 10,000 person-years, with other drugs 10 to 11.

Why dizziness on standing?

Cabergoline can lower blood pressure, especially when standing up quickly. In the placebo-controlled trial 15 percent had dizziness and 4 percent a drop in blood pressure on standing, 5 and 0 percent on placebo. The label advises checking blood pressure at the start and during use.

Can cabergoline affect behaviour?

Yes, the label lists impulse control disorders: new or stronger urges to gamble, increased sexual urges, uncontrolled spending and binge eating. Anyone noticing this should raise it with a doctor.

Which trials are running right now?

As of 26 October 2026 recruiting trials include a phase 3 trial with 382 planned participants against bromocriptine, a phase 3 trial on the safety of a higher dose in microprolactinomas and a phase 4 trial on metabolism in prolactinomas.

Relaterat

Relaterade produkter